CodeMap® 

11/18/2021 2020 Part B Utilization Data Loaded
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-January
2021-October

ASC Fee Schedule

2022-January
2021-October

APC Codes

2022-January
2021-October

DRG Codes

2022
2021

ASP Drug Pricing Files

January 2022
October 2021


CMS Transmittals



Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.


CodeMap® Compliance Briefing: 2/25/2011


Editor's Welcome: 

Each week, we receive many email inquiries from our subscribers concerning coding, reimbursement, coverage, and compliance issues associated with the Medicare and Medicaid programs. In recent months, one of the most frequent requests has been for clarification of the procedure codes providers must use to report drug screening procedures performed for beneficiaries of federally funded programs. Considering the number of changes CMS has made in the past two years concerning these codes, the number of inquiries concerning this issue is not surprising.

In addition, just this week, CMS published a MLN Matters Article (SE1105) concerning the codes used to report qualitative drug screens. In hopes of clearing up the significant confusion surrounding this topic, today's CodeMap® Compliance Briefing will once again attempt to explain the proper use of these procedure codes. As always, please feel free to email any questions, comments, or concerns to the author of this briefing. 

Si....

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap┬« is a Registered Trademark of Wheaton Partners, LLC.